JLL hires leading Life Sciences broker in San Francisco Bay Area amid rapid industry growth

SAN FRANCISCO, Oct. 24, 2022 – Amid rapid growth in the area’s life sciences industry, leading real estate and investment management firm JLL has announced that Allison Hoffmann has joined the market-leading Northern California life sciences team as Executive Vice President in JLL’s Silicon Valley office. She specializes in tenant representation for life sciences companies in the biotechnology, pharmaceutical and medical device space.

Hoffmann joins JLL Silicon Valley’s Life Sciences experts Scott W. Miller, Grant Dettmer, Cole Smith and Grant Yeatman. The team has helped lead the region’s life sciences industry to tremendous growth, and Hoffmann’s experience will continue to position the team as the market-leading life sciences team. Since 2020, JLL has been involved in 43% of all life sciences leasing volume in the Bay Area. 

“Allison brings an ideal mix of real estate experience and industry expertise to the team,” said Scott W. Miller, Executive Managing Director and JLL Bay Area Life Sciences Practice Group lead. “We’re excited to capitalize on her skill set and continue to propel our Tenant Representation business forward. We’re confident this investment will help complement the strength of our team and continue to generate excellent results for our clients.” 

Prior to joining JLL, Hoffmann was Managing Director of Life Sciences at T3 Advisors, a Savills Company. She began her career in healthcare working with Takeda Pharmaceuticals, Genentech and Gilead in sales and public relations positions. 

  “The San Francisco Bay Area continues to stand tall as one of the top life sciences clusters in the U.S., and, due to venture capital flows and access to skilled talent, its growth prospects continue to impress occupiers and investors,” said Travis McCready, Head of Life Sciences, Industries Americas, for JLL. “Allison’s expertise, background and reputation for sourcing innovative solutions makes her exceptionally qualified to advise and service clients and their specific needs. Looking forward, she will be a vital part of our life sciences team both regionally and nationally.” 

According to JLL’s 2022 Life Sciences Research Outlook & Cluster Rankings, the San Francisco Bay Area ranks second in the U.S. on the list of strongly positioned cluster markets, exhibiting the factors needed for continued opportunity and growth. This cluster model is defined by the key components of a successful life sciences ecosystem, including access to talent, funding and real estate infrastructure. 

Hoffmann earned a bachelor’s degree in Communications at the University of Colorado at Boulder and enjoys spending time exploring Northern California with her family when she is not working on the best possible deals for her clients. She is a member of The Board of Advisors for Life Science Cares Bay Area. 

JLL's vision is to reimagine the world of real estate, creating, finding, locating and operating safe and amazing spaces. JLL’s Life Sciences team of 3,000+ experienced professionals are a safe pair of hands to help biotechnology, pharmaceutical, medical devices organizations, investors and developers achieve their ambitions. JLL brings deep understanding of location analytics, project management, research advisory, financial incentives, transaction management, capital markets, real estate strategy and technology, facilities management, regulatory compliance and quality, and more. Our solutions help fuel innovation, enhance efficiency, improve financial performance and attract and retain top talent. Our team is trained and certified to operate within office and critical, regulated environments of lab and manufacturing space. To learn more, visit us.jll.com/lifesciences.

For more news, videos and research resources on JLL, please visit our newsroom.